safety and efficacy of cesnicabtagene autoleucel (ari0002h) for r/r mm
Published 2 years ago • 78 plays • Length 1:22Download video MP4
Download video MP3
Similar videos
-
4:13
real-world study determining the safety and efficacy of teclistamab in r/r multiple myeloma
-
1:57
the safety and efficacy of iberdomide for the treatment of multiple myeloma
-
2:12
safety and efficacy of linvoseltamab in patients with relapsed/refractory (r/r) multiple myeloma
-
2:39
the safety and efficacy of hbi0101 for the treatment of r/r myeloma
-
1:47
trials exploring the safety and efficacy of modakafusp alfa in r/r multiple myeloma: iinnovate
-
2:36
safety and preliminary efficacy of elotuzumab and belantamab mafodotin in patients with r/r myeloma
-
4:17
evaluating the safety and efficacy of elranatamab in multiple myeloma
-
2:57
linker-mm1: promising safety and efficacy of linvoseltamab in r/r multiple myeloma
-
4:58
overview of the toxicities associated with bispecific agents in multiple myeloma
-
11:11
3mensio ct pre-case planning: tavr with high coronary obstruction risk
-
2:48
what is plasma cell leukemia? #myeloma
-
2:32
the safety and efficacy of isatuximab for r/r myeloma: insights from icaria-mm, ikema & candor
-
1:17
efficacy & safety of standard of care cilta-cel in r/r multiple myeloma
-
2:08
safety, efficacy and tolerability of ide-cel in the real-world
-
1:45
real-world safety & efficacy of isatuximab-pomalidomide-dexamethasone in r/r multiple myeloma
-
2:29
the safety and feasibility of car-t & bispecifics in patients with myeloma after prior allosct
-
2:15
safety and efficacy of astx727 in patients with cmml from phase ii and phase iii ascertain studies
-
2:18
efficacy and safety results from the anchor trial
-
1:25
recent fda approval of exa-cel & lovo-cel for patients with scd
-
1:02
circulating plasma cell levels as a prognostic biomarker in myeloma
-
2:34
ruby & edithal trials: evaluating the safety and efficacy of edit-301 in scd & thalassemia
-
2:28
the encouraging results of the linker-mm1 trial: safety and efficacy of linvoseltamab in r/r myeloma